STERIS plc Appoints Daniel A. Carestio as Chief Operating Officer
August 06, 2018 at 04:31 pm EDT
Share
Daniel A. Carestio has been appointed Chief Operating Officer of the STERIS plc effective August 1, 2018. Mr. Carestio, age 45, previously served as the Company’s Senior Vice President, Sterilization and Disinfection, a position he assumed in February 2018. From August 2015 to February 2018, he served as Senior Vice President, STERIS Applied Sterilization Technologies and Life Sciences, and from 2011 to August 2015 he served as Vice President, Sales and Marketing for Isomedix Services and General Manager of Life Sciences.
STERIS plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows:
- sales of infection control solutions (62.9%): including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers and operating room equipment (including surgical tables, lighting and connectivity solutions). In addition, the group offers specialized healthcare services (sterilization services, instrument and endoscope repair and maintenance and customized process improvement consulting in acute care hospitals);
- development of applied sterilization solutions (22.1%): contract development of sterilization modalities and laboratory testing services for more than 50 sterilization and laboratory facilities worldwide;
- manufacturing of consumables and maintenance equipment (15%): dedicated to pharmaceutical manufacturers.
Net sales by source of income are divided into sales of services (53.5%), sales of consumables (23.4%) and sales of equipment (23.1%).
Net sales are distributed geographically as follows Ireland (2.3%), the United States (71.7%) and other (26%).